GlassScriptPhysician profile
Amir Arif
NPI 1437724903
$4,443.21
in general payments reported to CMS, 2019-2025
22 companies · $1,845 in 2025
The $1,845 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,423 · 2023: $787 · 2024: $388 · 2025: $1,845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,075 · Travel and Lodging: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,074.97 |
| Travel and Lodging | $945.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $1,200.00 | 2022 | |
| Treace Medical Concepts, INC. | $1,002.73 | 2024-2025 | |
| Stryker Corporation | $584.90 | 2023-2025 | Prostep, Prophecy, Allowrap |
| Depuy Synthes Sales INC. | $278.46 | 2023-2025 | Na, Motoband, Minibunion |
| Medtronic, INC. | $196.49 | 2022-2025 | Intellis Adaptivestim |
| Smith+Nephew, INC. | $144.45 | 2023-2025 | Stravix, Collagenase Santyl |
| Integra Lifesciences Corporation | $131.50 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Sanara Medtech INC. | $120.74 | 2023 | Celleraterx |
| Amgen INC. | $119.70 | 2024 | Krystexxa |
| Horizon Therapeutics Plc | $107.05 | 2023 | Krystexxa |
| Kerecis Limited | $79.67 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Enduromed, LLC | $72.45 | 2025 | |
| Organogenesis INC. | $71.91 | 2025 | Puraply Wound Matrix, Affinity, Simplimax |
| Paragon 28, INC. | $71.59 | 2022-2024 | Bun-Yo-Matic, Ttc Nail |
| Paratek Pharmaceuticals, INC. | $69.91 | 2025 | Nuzyra |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $55.48 | 2025 | Tirosint, Flector, Licart |
| Solventum Corporation | $35.03 | 2025 | Prevena, Activ.A.C., V.A.C. Veraflo |
| Fusion Orthopedics USA, LLC | $26.62 | 2025 | |
| Melinta Therapeutics, LLC | $23.87 | 2025 | Orbactiv, Kimyrsa |
| Grt US Holding, INC. | $18.64 | 2022 | |
| Bioventus LLC | $16.11 | 2023 | Exogen Ultrasound Bone Healing System |
| Hartmann USA, INC. | $15.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Arif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.